ICU Medical’s Smiths Medical unit reportedly plans to close a New Hampshire manufacturing facility that houses about 220 employees.
The infusion technology maker plans to close the plant in Keene, New Hampshire, next year, according to the Keene Sentinel. The outlet said VP of Global Marketing, Tom McCall, confirmed the decision to close today after employees received word yesterday.
McCall reportedly told the Sentinel that the decision came as a result of a manufacturing capability redundancy following ICU Medical’s $2.35 billion acquisition of the company in 2022. The VP said the company decided that it needed to consolidate its manufacturing footprint and transfer the manufacturing from Keene to other locations.
Smiths Medical’s business includes syringe and ambulatory infusion devices, vascular access and vital care products. The company has faced some significant challenges over the past few months, including:
- Warnings of an issue with Portex tracheotomy tubes.
- An FDA Class I recall — the most serious kind — for certain ventilator systems.
- An April 3 warning on CADD-Solis infusion pump software.
- A software recall affecting nearly 86,000 Medfusion infusion pump systems.
